OPKO HEALTH, INC.
For the period ended Dec 31, 2025. Filed Feb 26, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Feb 26, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 2. Properties
Our principal corporate office is located at 4400 Biscayne Blvd, Miami, Florida. We lease this space from Frost Real Estate Holdings, LLC (“Frost Real Estate”), an entity which is controlled by Dr. Phillip Frost, our Chairman of the Board and Chief Executive Officer. Pursuant to the lease agreement with Frost Real Estate, we lease approximately 26,328 square feet, which encompasses space for our corporate offices and administrative services.
The table below summarizes certain information as to our significant physical properties as of December 31, 2025:
| Location | Segment and Purpose | Type of Occupancy |
|---|---|---|
| Miami, FL | Diagnostics & Pharmaceutical: Corporate Headquarters | Leased |
| Weston, Massachusetts | Pharmaceuticals: Research and Development | Leased |
| Elmwood Park, NJ | Diagnostics: Main Laboratory | Leased |
| Kiryat Gat, Israel | Pharmaceuticals: Research and Development, CTP | Leased |
| Guadalajara, Mexico | Pharmaceuticals: Pharmaceutical Manufacturing | Owned |
| Banyoles, Spain | Pharmaceuticals: Pharmaceutical Manufacturing | Owned |
| Palol de Revardit, Spain | Warehouse | Leased |
| Barcelona, Spain | Pharmaceuticals: Research and Development | Owned |
| Waterford, Ireland | Pharmaceuticals: Pharmaceutical Manufacturing | Leased |
| Santiago, Chile | Pharmaceuticals: Office; Warehouse | Leased |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.